Affiliation:
1. Department of Obstetrics and Gynecology University of Helsinki Helsinki Finland
2. Department of Obstetrics and Gynecology Helsinki University Hospital Helsinki Finland
3. Knowledge Brokers, Finnish Institute for Health and Welfare Helsinki Finland
4. Department of Molecular Medicine and Surgery Karolinska Institute Stockholm Sweden
5. Region Stockholm, Academic Primary Health Care Center Stockholm Sweden
Abstract
AbstractIntroductionWomen undergoing an induced abortion are highly fertile and at risk of subsequent unplanned pregnancy. We recently completed a randomized clinical trial showing that routine provision of intrauterine device (IUD) at the time of abortion significantly reduced the risk of subsequent abortion during a 5‐year follow up. As the use of highly effective contraception may affect all subsequent pregnancies, we analyzed the rate and distribution of all subsequent pregnancies (deliveries, miscarriages, and abortions), and the risk factors for these various pregnancy outcomes in the above‐mentioned randomized clinical trial.Material and methodsWe enrolled adult women requesting first‐trimester induced abortion and candidates for IUD for post‐abortion contraception. Women (n = 751) were randomized to receive an IUD (either levonorgestrel‐releasing IUD or copper IUD) by the clinic responsible for abortion care vs. routine care of IUD provision in primary health care with oral contraceptives for interval contraception. In the present secondary analysis, we identified all deliveries, miscarriages, and abortions in the intervention (n = 375) and control (n = 373) cohorts during the 5‐year follow up using the Finnish national registries. The trial is registered at Clinical Trials (NTC01223521).ResultsThe overall delivery, miscarriage, and abortion rates were 42.0, 12.0 and 32.1/1000 years of follow up (yFU). Any new pregnancy occurred in 98 women in the intervention and in 129 women in the control cohort (hazard ratio 0.73, 95% confidence interval 0.56–0.95, p = 0.023). The effect of routine IUD provision in reducing pregnancies was limited to the first 2 yFU. The number of subsequent induced abortions and of women undergoing it were significantly reduced, and time to abortion was prolonged by the intervention. However, the overall number, the number of women with subsequent delivery or miscarriage, and the times to these events were not significantly affected. History of previous pregnancy (delivery or abortion) and smoking were risk factors for subsequent induced abortion, but not for delivery or miscarriage.ConclusionsRoutine provision of IUD as part of abortion care did not reduce the rates of delivery or miscarriage during the 5‐year follow up. The rates of all pregnancies and the need of subsequent induced abortion were reduced by IUD provision during the first 2 yFU.
Funder
Finska Läkaresällskapet
Helsingin ja Uudenmaan Sairaanhoitopiiri
Jenny ja Antti Wihurin Rahasto
Suomen Lääketieteen Säätiö
Yrjö Jahnssonin Säätiö
Subject
Obstetrics and Gynecology,General Medicine
Reference20 articles.
1. NICE.Long‐acting reversible contraception | Clinical guideline.2019. Accessed March 22 2023.https://www.nice.org.uk/guidance/cg30/chapter/1‐Recommendations
2. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review
3. Long-Acting Reversible Contraception Free of Charge, Method Initiation, and Abortion Rates in Finland
4. The American College of Obstetrician and Gynecologists. Accessed March 22 2023.https://www.acog.org/womens‐health/faqs/long‐acting‐reversible‐contraception‐iud‐and‐implant
5. Centers for Disease Control. 2016. Accessed March 22 2023.https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html